Skip to content

HydroMARK Breast Biopsy Site Marker CA000413003Recalls & reported problems

Devicor Medical Products, Inc. · HydroMARK Breast Biopsy Site Marker- CE · Class 2 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00841911102182), received between Dec 6, 2024 and Dec 6, 2024 — classified as 1 injury.

The most frequently reported specific device problem is “Patient Device Interaction Problem” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 1 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Patient Device Interaction Problem1

Patient problems

  • Hypersensitivity/Allergic reaction1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryDec 6, 2024Patient Device Interaction Problem; Patient Device Interaction Problem

    ACCORDING TO THE REPORTER, THE PATIENT REQUIRED A BIOPSY AS A RESULT OF A ROUTINE PRE-OPERATIVE SCREENING MAMMOGRAM BEFORE BREAST REDUCTION PROCEDURE. THE EVENT HAPPENED AFTER CLIP PLACEMENT/BIOPSY SITE MARKING. THE EVENT OCCURRED USING STEREOTACTIC (ST) DEPLOYMENT, USING HOLOGIC ATEC VACUUM ASSISTED BIOPSY (VAB). THE MARKER DEPLOYED ON (B)(6) 2024 SUCCESSFULLY HOWEVER, AFTER A COUPLES OF DAYS, REDNESS, PAIN AND SWELLING WAS OBSERVED BY THE PATIENT. PRIOR TO DEPLOYMENT, IRON WAS DISCLOSED AS AN ALLERGY. THE PROCEDURE WAS COMPLETED. DURING THE PATIENT'S BREAST REDUCTION PROCEDURE ON (B)(6) 2024, HOOK WIRE WAS PLACED TO ENSURE THE MARKER CLIP WAS REMOVED. MARKER REMOVAL WAS NOT THE GOAL OF THE SURGERY.

    Patient problems: Hypersensitivity/Allergic reaction

    MAUDE report 20864127 ↗

Other Marker, Radiographic, Implantable devices

All Marker, Radiographic, Implantable devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page